🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a Phase 2, randomized, double-blind, placebo-controlled study, enr...
Status
Completed
Location
The University of Washington Medical Center
Start Date
2015-01-15
Trial ID
NCT02245620
Treatments Being Tested
This is a Phase 2, prospective, randomized, double-masked, vehicle controll...
Status
Completed
Location
Doheny Eye Center
Start Date
2016-03
Trial ID
NCT02693119
Treatments Being Tested
This was a Phase 2a prospective, single center, randomized, double-blind, p...
Status
Terminated
Location
Mayo Clinic
Start Date
2012-12
Trial ID
NCT01755858
This is a Phase 1/2 prospective, randomized, double-masked, and vehicle-con...
Status
Completed
Location
Cincinnati Eye Institute
Start Date
2016-02
Trial ID
NCT02653391
This study is a Phase 1, open-label, parallel group, multiple dose study, i...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02436447
This is an open-label, Phase 1 single-center study in approximately 40 subj...
Status
Completed
Location
Duke University School of Medicine / Dept. of Ophthalmology (Duke Eye Center)
Start Date
2016-10-28
Trial ID
NCT02848313
Treatments Being Tested
This study is a single-center, randomized, double-blind, placebo-controlled...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02388529
A randomized, double-masked, placebo-controlled study to evaluate the safet...
Status
Completed
Location
Associated Retina Consultants, Ltd.
Start Date
2019-03-27
Trial ID
NCT03891875
This is a phase 2 randomized, double-blind, placebo-controlled study to eva...
Status
Completed
Location
Hospital Onze Lieve Vrouw campus Aalst
Start Date
2016-10-20
Trial ID
NCT02914665
Treatments Being Tested